DOJ Obtains Guilty Plea for Online Sales of SARMs That Continued Despite FDA Warning Letter
October 23, 2024 at 03:20 PM EST
Continuing its series of enforcement actions targeting the illegal marketing of selective androgen receptor modulators (SARMs), chemical substances that mimic the effects of anabolic steroids, the Department of Justice (DOJ) has obtained a guilty plea from a Simi Valley, California, resident for marketing unapproved new drugs with the intent to defraud and mislead (United Stat... Read More
